Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 3, NDA AUTHORIZED GENERIC 1.
| Dosage form | NDCs |
|---|---|
| solution | 2 |
| tablet, film coated | 2 |
| Route | NDCs |
|---|---|
| nasal | 2 |
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| lxo us inc. | 3 |
| lxo us inc. | 1 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| COCAINE HYDROCHLORIDE | COCAINE HYDROCHLORIDE | solution, nasal | 70839-362NDA AUTHORIZED GENERIC |
| Goprelto | cocaine hydrochloride | solution, nasal | 70839-359NDA |
| Tekturna | aliskiren hemifumarate | tablet, film coated, oral | 70839-150NDA |
| Tekturna | aliskiren hemifumarate | tablet, film coated, oral | 70839-300NDA |
Compare
Other companies listing aliskiren hemifumarate
- Jubilant Biosys Limited1 site · 94 NDC
- Prasco Laboratories0 sites · 106 NDC
Enquiry
Common questions
- Is LXO US Inc. FDA approved?
- LXO US Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does LXO US Inc. make?
- 4 products are listed under LXO US Inc. in the openFDA NDC Directory, most often as solution; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.